Cargando…
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874329/ https://www.ncbi.nlm.nih.gov/pubmed/32692582 http://dx.doi.org/10.1164/rccm.202002-0460OC |
_version_ | 1783649570579808256 |
---|---|
author | Invernizzi, Rachele Wu, Benjamin G. Barnett, Joseph Ghai, Poonam Kingston, Shaun Hewitt, Richard J. Feary, Johanna Li, Yonghua Chua, Felix Wu, Zhe Wells, Athol U. George, Peter M. Renzoni, Elisabetta A. Nicholson, Andrew G. Rice, Alexandra Devaraj, Anand Segal, Leopoldo N. Byrne, Adam J. Maher, Toby M. Lloyd, Clare M. Molyneaux, Philip L. |
author_facet | Invernizzi, Rachele Wu, Benjamin G. Barnett, Joseph Ghai, Poonam Kingston, Shaun Hewitt, Richard J. Feary, Johanna Li, Yonghua Chua, Felix Wu, Zhe Wells, Athol U. George, Peter M. Renzoni, Elisabetta A. Nicholson, Andrew G. Rice, Alexandra Devaraj, Anand Segal, Leopoldo N. Byrne, Adam J. Maher, Toby M. Lloyd, Clare M. Molyneaux, Philip L. |
author_sort | Invernizzi, Rachele |
collection | PubMed |
description | Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in the lower airways in CHP. Objectives: To characterize and compare the airway microbiome in subjects with CHP, subjects with idiopathic pulmonary fibrosis (IPF), and control subjects. Methods: We prospectively recruited individuals with a CHP diagnosis (n = 110), individuals with an IPF diagnosis (n = 45), and control subjects (n = 28). Subjects underwent BAL and bacterial DNA was isolated, quantified by quantitative PCR and the 16S ribosomal RNA gene was sequenced to characterize the bacterial communities in the lower airways. Measurements and Main Results: Distinct differences in the microbial profiles were evident in the lower airways of subjects with CHP and IPF. At the phylum level, the prevailing microbiota of both subjects with IPF and subjects with CHP included Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. However, in IPF, Firmicutes dominated, whereas the percentage of reads assigned to Proteobacteria in the same group was significantly lower than the percentage found in subjects with CHP. At the genus level, the Staphylococcus burden was increased in CHP, and Actinomyces and Veillonella burdens were increased in IPF. The lower airway bacterial burden in subjects with CHP was higher than that in control subjects but lower than that of those with IPF. In contrast to IPF, there was no association between bacterial burden and survival in CHP. Conclusions: The microbial profile of the lower airways in subjects with CHP is distinct from that of IPF, and, notably, the bacterial burden in individuals with CHP fails to predict survival. |
format | Online Article Text |
id | pubmed-7874329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Thoracic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-78743292021-02-11 The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis Invernizzi, Rachele Wu, Benjamin G. Barnett, Joseph Ghai, Poonam Kingston, Shaun Hewitt, Richard J. Feary, Johanna Li, Yonghua Chua, Felix Wu, Zhe Wells, Athol U. George, Peter M. Renzoni, Elisabetta A. Nicholson, Andrew G. Rice, Alexandra Devaraj, Anand Segal, Leopoldo N. Byrne, Adam J. Maher, Toby M. Lloyd, Clare M. Molyneaux, Philip L. Am J Respir Crit Care Med Original Articles Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no study has investigated the composition of microbial communities in the lower airways in CHP. Objectives: To characterize and compare the airway microbiome in subjects with CHP, subjects with idiopathic pulmonary fibrosis (IPF), and control subjects. Methods: We prospectively recruited individuals with a CHP diagnosis (n = 110), individuals with an IPF diagnosis (n = 45), and control subjects (n = 28). Subjects underwent BAL and bacterial DNA was isolated, quantified by quantitative PCR and the 16S ribosomal RNA gene was sequenced to characterize the bacterial communities in the lower airways. Measurements and Main Results: Distinct differences in the microbial profiles were evident in the lower airways of subjects with CHP and IPF. At the phylum level, the prevailing microbiota of both subjects with IPF and subjects with CHP included Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. However, in IPF, Firmicutes dominated, whereas the percentage of reads assigned to Proteobacteria in the same group was significantly lower than the percentage found in subjects with CHP. At the genus level, the Staphylococcus burden was increased in CHP, and Actinomyces and Veillonella burdens were increased in IPF. The lower airway bacterial burden in subjects with CHP was higher than that in control subjects but lower than that of those with IPF. In contrast to IPF, there was no association between bacterial burden and survival in CHP. Conclusions: The microbial profile of the lower airways in subjects with CHP is distinct from that of IPF, and, notably, the bacterial burden in individuals with CHP fails to predict survival. American Thoracic Society 2021-02-01 2021-02-01 /pmc/articles/PMC7874329/ /pubmed/32692582 http://dx.doi.org/10.1164/rccm.202002-0460OC Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Articles Invernizzi, Rachele Wu, Benjamin G. Barnett, Joseph Ghai, Poonam Kingston, Shaun Hewitt, Richard J. Feary, Johanna Li, Yonghua Chua, Felix Wu, Zhe Wells, Athol U. George, Peter M. Renzoni, Elisabetta A. Nicholson, Andrew G. Rice, Alexandra Devaraj, Anand Segal, Leopoldo N. Byrne, Adam J. Maher, Toby M. Lloyd, Clare M. Molyneaux, Philip L. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis |
title | The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis |
title_full | The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis |
title_fullStr | The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis |
title_full_unstemmed | The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis |
title_short | The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis |
title_sort | respiratory microbiome in chronic hypersensitivity pneumonitis is distinct from that of idiopathic pulmonary fibrosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874329/ https://www.ncbi.nlm.nih.gov/pubmed/32692582 http://dx.doi.org/10.1164/rccm.202002-0460OC |
work_keys_str_mv | AT invernizzirachele therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT wubenjaming therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT barnettjoseph therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT ghaipoonam therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT kingstonshaun therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT hewittrichardj therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT fearyjohanna therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT liyonghua therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT chuafelix therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT wuzhe therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT wellsatholu therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT georgepeterm therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT renzonielisabettaa therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT nicholsonandrewg therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT ricealexandra therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT devarajanand therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT segalleopoldon therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT byrneadamj therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT mahertobym therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT lloydclarem therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT molyneauxphilipl therespiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT invernizzirachele respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT wubenjaming respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT barnettjoseph respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT ghaipoonam respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT kingstonshaun respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT hewittrichardj respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT fearyjohanna respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT liyonghua respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT chuafelix respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT wuzhe respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT wellsatholu respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT georgepeterm respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT renzonielisabettaa respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT nicholsonandrewg respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT ricealexandra respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT devarajanand respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT segalleopoldon respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT byrneadamj respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT mahertobym respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT lloydclarem respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis AT molyneauxphilipl respiratorymicrobiomeinchronichypersensitivitypneumonitisisdistinctfromthatofidiopathicpulmonaryfibrosis |